TO THE EDITOR
I am a bachelor-degreed pharmacist who does not believe that everyone filling a prescription needs a PharmD.1 In my experience, expanding PharmD programs has reduced the supply of pharmacists in a market that is experiencing a staggering demand for practitioners. This is a prescription for higher costs through higher wage demands.
When the University of Colorado School of Pharmacy switched to a PharmD program, it decreased its available enrollment from 120 students to 90. The Colorado legislature had given the university no budget increase. To spend the same amount to educate students for 4 years as it did for 3, the school was forced to reduce enrollment by 25%. In the not too distant past, insurance companies allowed up to 100 tablets to be dispensed on one prescription. When they switched to authorizing a 30-day supply, this meant many more prescriptions were dispensed. Many 100-tablet prescriptions that could have been dispensed in their original container now had to be counted with 30 tablets being dispensed.
This has lengthened the time to fill a prescription, yet customers are less patient to wait. So the retail pharmacy chains in the US are building many more stores. For example, in 2000, Walgreen’s opened a store on the average of 1 every 19 hours, and it will continue to do so throughout 2001. Yet there are only so many pharmacists in the pool. To get them Walgreen’s is paying huge salaries. A colleague recently accepted a position at Walgreen’s at a $19.00 per hour raise! Walgreen’s has been quoted as saying it would be happy if it could hire every pharmacy graduate in the 2001 class. Think of that!—none for anyone else.
If you were offered a $19.00 an hour pay raise would you accept? There are only a few of us who are willing to stay in hospitals, and we are being very tempted. There will probably be another class of pharmacists soon.
Al Lodwick, RPh, MA
St. Mary-Corwin Medical Center
Pueblo, CO
1. Montoya ID. Is the healthcare workforce a barrier to cost containment? Am J Manag Care 2000;6:971-972.
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More